HomeAI · summaries
Storia in 3 fonti
AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
Europe's CHMP backed AstraZeneca's camizestrant for breast cancer, diverging from a recent FDA committee vote, as well as Novo Nordisk's Wegovy pill for obesity.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
EU and US advisers split over AstraZeneca breast cancer drug
Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The Readout
- ·
fiercepharma.com
Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
Less than a month after an FDA advisory committee voted 6-3 | Less than a month after an FDA advisory committee recommended rejection of AstraZeneca’s novel cancer drug, Europe’s…
